| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/03/2006 | CN1765391A Chinese herbal decoction for treating qi and blood deficiency pattern dizziness and preparation method |
| 05/03/2006 | CN1765386A Chinese herbal decoction for treating apontaneous emission of kidney-qi unsolidation pattern and preparation method thereof |
| 05/03/2006 | CN1765381A Conditioning qi-invigorating weight-reducing extract |
| 05/03/2006 | CN1765377A Orally administered formulation of eight ingredients-containing 'Xi Lei San' and its colon target oral formulation and preparation method |
| 05/03/2006 | CN1765374A Preparation method of ganoderma lucidum chewable tablet and product |
| 05/03/2006 | CN1765367A Vitamine U, belladonna and aluminiium dispersible tablet and its preparation process |
| 05/03/2006 | CN1765366A Peony total glucosides tablet and its preparation method |
| 05/03/2006 | CN1254541C Novel compound |
| 05/03/2006 | CN1254529C Health-caring wine and its processing method |
| 05/03/2006 | CN1254484C Solid-phase synthesis process of octreotide acetate |
| 05/03/2006 | CN1254473C Process for crystallization of(R)-or(S)-lansoprazole |
| 05/03/2006 | CN1254469C Arylsulfonyl derivatives with 5-HT6 receptor affinity |
| 05/03/2006 | CN1254267C Medicine for treating gastral cavity pain and its preparation method |
| 05/03/2006 | CN1254256C Compound dantong tablet (film coating tablet for disorder of gallbladder) and its manufacturing method |
| 05/03/2006 | CN1254251C Composition of pharmaceutical and preparation process thereof |
| 05/03/2006 | CN1254240C Silibinin meglumine salt oral disintegration tablet and its preparing method |
| 05/03/2006 | CN1254234C Plasmid DNA (Lipogenes TM) and encapsulating therapeutica agent containing karyon-positioning signal /fusion-promoting peptide conjugate into targeted liposomes complex |
| 05/03/2006 | CN1254191C Process and composition for controlling fecal hair excretion and trichobezoar formation |
| 05/03/2006 | CN1254187C Ice-cream for preventing decayed tooth |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 05/02/2006 | US7038061 Analgesics; anesthetics; antiinflammatory agents; central nervous system duisorders; strokes; antiarthritic agents; inflammatory bowel disorders |
| 05/02/2006 | US7038048 Compositions for treatment of cell proliferation disorders |
| 05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
| 05/02/2006 | US7037926 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037709 Comprises nucleotide sequences coding microsomal enzymes for detoxification of xenobiotic compounds in liver; drug screening; gene therapy |
| 05/02/2006 | US7037666 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | US7037533 Functional agent for decomposing nicotine and method of preparing the same |
| 05/02/2006 | US7037504 Resistant to proteolysis, and gene sequences encoding these forms and having codons optimized for usage by an industrial production organism, are provided. |
| 05/02/2006 | US7037377 preparing raw material liquid so that lactulose content within powder produced following spray drying is 10 to 50% by weight, protein content is 0.2 to 9.0 parts by weight per 1 part by weight of lactulose, and chlorine content is no more than 0.08 parts by weight per 1 part by weight of protein, drying |
| 05/02/2006 | CA2401191C A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer |
| 05/02/2006 | CA2334012C 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 05/02/2006 | CA2250426C Amidinohydrazones as protease inhibitors |
| 05/02/2006 | CA2174544C Method for using pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines as adrenergic agents |
| 05/02/2006 | CA2173974C Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 04/27/2006 | WO2006044741A1 Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease |
| 04/27/2006 | WO2006044529A1 Compositions containing lipase; protease and amylase for treating pancreatic insufficiency |
| 04/27/2006 | WO2006044504A1 Cgrp receptor antagonists |
| 04/27/2006 | WO2006043722A1 Chimeric (double) decoy |
| 04/27/2006 | WO2006043671A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
| 04/27/2006 | WO2006043623A1 Method of preventing or treating hepatopathy |
| 04/27/2006 | WO2006042950A2 Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 04/27/2006 | WO2006042728A2 Use of stable ammonium liponate salts for the treatment of diabetic and other disorders |
| 04/27/2006 | WO2005101004A3 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 04/27/2006 | WO2005077462A3 Cd70 inhibition for the treatment and prevention of inflammatory bowel disease |
| 04/27/2006 | US20060089404 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 04/27/2006 | US20060089394 {[2-Methyl-4-({[4'-(trifluoromethyl)-3-biphenylyl]methyl}thio)phenyl]oxy}acetic acid; adipogenic signalling cascade and lipid homeostasis; increase High Density Lipoproteins; hypotensive agent; Syndrome X, obesity, insulin resistance, cardiovascular disorder |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089379 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 04/27/2006 | US20060089353 Indole derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2006 | US20060089345 Indole derivatives, method for preparating same and pharmaceutical compositions containing same |
| 04/27/2006 | US20060089334 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 04/27/2006 | US20060089326 Immunostimulatory nucleic acid molecules |
| 04/27/2006 | US20060089312 Protease inhibitors |
| 04/27/2006 | US20060089310 Treatment of infections and other disorders |
| 04/27/2006 | US20060089299 Selective treatment of endothelial somatostatin receptors |
| 04/27/2006 | US20060088915 A G protein-coupled receptor protein for the treatment of digestive diseases |
| 04/27/2006 | US20060088890 Identification and isolation of somatic stem cells and uses thereof |
| 04/27/2006 | US20060088884 Administering brain-derived neurotrophic factor in its native sequence to an oocyte; stimulation of oocyte maturation alleviates an infertility condition |
| 04/27/2006 | US20060088561 solidifying agent consists of long chain fatty alcohol; carrier is semi-solid at rest and liquefies upon application of shear forces |
| 04/27/2006 | US20060088545 Use of inhibitors of the protease of the human immunodeficiency virus (hiv) to block cell migration and/or invasion, tissue infiltration and oedema for the therary of diseases associated therewith |
| 04/27/2006 | US20060088502 Drug for reducing side effects in ribavirin interferon combination therapy |
| 04/27/2006 | DE10235475B4 Arzneimittel mit einer Benzimidazolverbindung im Gemisch mit mikrokristalliner Cellulose und Verfahren zu deren Herstellung Drugs with a benzimidazole compound in mixture with microcrystalline cellulose and process for their preparation |
| 04/27/2006 | DE10034494B4 Verfahren zur Herstellung eines Extrakts von amerikanischem Ginseng Process for the preparation of an extract from American ginseng |
| 04/27/2006 | CA2584655A1 Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease |
| 04/27/2006 | CA2584385A1 Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same |
| 04/27/2006 | CA2584069A1 Compositions containing lipase; protease and amylase for treating pancreatic insufficiency |
| 04/27/2006 | CA2583576A1 Chimera (double) decoy |
| 04/27/2006 | CA2583536A1 Cgrp receptor antagonists |
| 04/27/2006 | CA2583363A1 Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 04/26/2006 | EP1650221A2 Novel compounds |
| 04/26/2006 | EP1650205A1 Cyclohexanecarboxylic acid compound |
| 04/26/2006 | EP1650201A1 Benzoxazepine compound |
| 04/26/2006 | EP1650199A1 Sulfonamide derivative having isoxazole ring |
| 04/26/2006 | EP1650195A1 Method of inhibiting production of osteopontin |
| 04/26/2006 | EP1650193A2 6-Phenylphenanthridines with PDE-IV inhibiting activity |
| 04/26/2006 | EP1650189A1 Benzylamine derivative |
| 04/26/2006 | EP1649864A1 Periodontal disease therapeutic and/or preventive composition |
| 04/26/2006 | EP1649856A2 Use of pimecrolimus for selective immunomodulation |
| 04/26/2006 | EP1648880A1 Therapeutic agents useful for treating pain |
| 04/26/2006 | EP1648563A1 Carbostyril derivatives for accelerating salivation |
| 04/26/2006 | EP1648482A2 Use of a cosmetic or pharmaceutical composition, comprising a lupeol-rich extract as an active ingredient for stimulating the synthesis of heat shock proteins |
| 04/26/2006 | EP1648397A2 Ex vivo progenitor and stem cell expansion for use in the treatment of disease of endodermally-derived organs |
| 04/26/2006 | EP1421377B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 04/26/2006 | EP1414802B1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 04/26/2006 | EP1320710B1 Drying method for selectively removing volatile components from wet coatings |
| 04/26/2006 | EP1303286B1 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/26/2006 | CN1764662A Cyclic benzimidazoles. |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764476A Composition and method for the treatment and prevention of enteric bacterial infections |
| 04/26/2006 | CN1764463A Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood |
| 04/26/2006 | CN1764453A Therapeutic formulation for mainly of diarrhea large intesitine irritation syndrome |
| 04/26/2006 | CN1764448A A protectant of periodontal membranes |
| 04/26/2006 | CN1764432A Gargle for treating or preventing bacterial infection and fungus infection |
| 04/26/2006 | CN1763168A Novel production process for invigorative liquor and medicated liquor |
| 04/26/2006 | CN1763089A C-terminal amino acid lactone modified extrasin alpha-1 and its uses |
| 04/26/2006 | CN1763071A Chinese Elder Herb general triterpene extraction process |
| 04/26/2006 | CN1763064A Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression |
| 04/26/2006 | CN1762967A Enoxolone derivative, preparation method and uses |